The induction of immunogenic cell death by type II anti-CD20 monoclonal antibodies has mechanistic differences compared with type I rituximab

British Journal of Haematology

Volumn 162, Issue 6, 2013, Pages 842-845

  Cheadle, Eleanor J ^a   Sidon, Lauren ^a   Dovedi, Simon J ^a   Melis, Monique H M ^a,b   Alduaij, Waleed ^a   Illidge, Tim M ^a   Honeychurch, Jamie ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

CD20; Cell death; DAMP; Lymphoma; Monoclonal antibody

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD20 MONOCLONAL ANTIBODY TYPE II; CELL PROTEIN; CHAPERONIN 60; DAMAGE ASSOCIATED MOLECULAR PATTERN PROTEIN; HEAT SHOCK PROTEIN 90; HIGH MOBILITY GROUP B1 PROTEIN; LATRUNCULIN B; MITOXANTRONE; MONOCLONAL ANTIBODY; OBINUTUZUMAB; OFATUMUMAB; RITUXIMAB; TOSITUMOMAB; TRASTUZUMAB; TYPE I RITUXIMAB; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL DEATH; CELL MATURATION; CELL PERMEABILIZATION; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOGENIC CELL DEATH; IMMUNOGENICITY; LETTER; LYMPHATIC SYSTEM TUMOR; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE ACTIVATION;

CD20; CELL DEATH; DAMP; LYMPHOMA; MONOCLONAL ANTIBODY;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; CELL DEATH; DENDRITIC CELLS; HUMANS;

EID: 84883273173     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12427     Document Type: Letter

References (10)

1. Abes, R., Gelize, E., Fridman, W.H. & Teillaud, J.L. (2010) Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response. Blood, 116, 926-934.
2. Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M.C., Ullrich, E., Saulnier, P., Yang, H., Amigorena, S., Ryffel, B., Barrat, F.J., Saftig, P., Levi, F., Lidereau, R., Nogues, C., Mira, J.P., Chompret, A., Joulin, V., Clavel-Chapelon, F., Bourhis, J., Andre, F., Delaloge, S., Tursz, T., Kroemer, G. & Zitvogel, L. (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Medicine, 13, 1050-1059.
3. Basu, S., Binder, R.J., Suto, R., Anderson, K.M. & Srivastava, P.K. (2000) Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. International Immunoogy, 12, 1539-1546.
4. Braza, M.S., Klein, B., Fiol, G. & Rossi, J.F. (2011) gammadelta T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody. Haematologica, 96, 400-407.
5. Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., Perfettini, J.L., Schlemmer, F., Tasdemir, E., Uhl, M., Genin, P., Civas, A., Ryffel, B., Kanellopoulos, J., Tschopp, J., Andre, F., Lidereau, R., McLaughlin, N.M., Haynes, N.M., Smyth, M.J., Kroemer, G. & Zitvogel, L. (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nature Medicine, 15, 1170-1178.
6. Griffith, T.S. & Ferguson, T.A. (2011) Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells. Immunity, 35, 456-466.
7. Hilchey, S.P., Hyrien, O., Mosmann, T.R., Livingstone, A.M., Friedberg, J.W., Young, F., Fisher, R.I., Kelleher, R.J. Jr, Bankert, R.B. & Bernstein, S.H. (2009) Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab. Blood, 113, 3809-3812.
8. Honeychurch, J., Alduaij, W., Azizyan, M., Cheadle, E.J., Pelicano, H., Ivanov, A., Huang, P., Cragg, M.S. & Illidge, T.M. (2012) Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway. Blood, 119, 3523-3533.
9. Niederfellner, G., Lammens, A., Mundigl, O., Georges, G.J., Schaefer, W., Schwaiger, M., Franke, A., Wiechmann, K., Jenewein, S., Slootstra, J.W., Timmerman, P., Brannstrom, A., Lindstrom, F., Mossner, E., Umana, P., Hopfner, K.P. & Klein, C. (2011) Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies. Blood, 118, 358-367.
10. Wahlin, B.E., Sundstrom, C., Holte, H., Hagberg, H., Erlanson, M., Nilsson-Ehle, H., Linden, O., Nordstrom, M., Ostenstad, B., Geisler, C.H., Brown Pde, N., Lehtinen, T., Maisenholder, M., Tierens, A.M., Sander, B., Christensson, B. & Kimby, E. (2011) T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab. Clinical Cancer Research, 17, 4136-4144.